Aseptic Processing & Packaging Materials Market Size & Share 2026-2035
Market Size – By Offering Type (Aseptic Processing Materials, Aseptic Packaging Materials), By Material Type (Paper & Paperboard, Plastic, Metal, Glass, Others), and By Application (Food, Beverages, Pharmaceutical, Cosmetics & Personal Care, Others), Growth Forecast. The market forecasts are provided in terms of revenue (USD) & volume (Kilo Tons).
Download Free PDF

Aseptic Processing & Packaging Materials Market Size
The global aseptic processing & packaging materials market was valued at USD 57.5 billion in 2025. It is projected to grow from USD 61.8 billion in 2026 to USD 118.8 billion by 2035, representing 7.5% CAGR from 2026 to 2035, according to latest report published by Global Market Insights Inc.
Aseptic Processing & Packaging Materials Market Key Takeaways
Market Size & Growth
Regional Dominance
Key Market Drivers
Challenges
Opportunity
Key Players
Aseptic Processing & Packaging Materials Market Trends
Aseptic Processing & Packaging Materials Market Analysis
Based on offering type, the aseptic processing & packaging materials market is segmented into aseptic processing materials and aseptic packaging materials. The aseptic packaging materials sub-segment was valued at USD 47.15 Billion in 2025, and it is anticipated to expand to 7.3% of CAGR during 2026-2035.
Based on material type, the aseptic processing & packaging materials market is segmented into Paper & Paperboard, Plastic, Metal, Glass, and Others. The Paper & Paperboard segment was valued at USD 19.7 billion with a market share of 34% in 2025, and it is anticipated to expand at a CAGR of 7.4% during 2026–2035.
North America's aseptic processing & packaging materials market share is 25.5% of the total global revenues in 2025, followed by the growth rate of 7.1% CAGR till 2035, which is driven by the dual demand of pharmaceutical manufacturing investment and Food Safety Regulation enforcement. Single units of aseptic bioreactors are becoming readily available, reflecting the growing demand for materials in a compounded form, as the US-based CDMOs such as Samsung Biologics' planned joint venture expansion in the United States and Lonza Biologics' Portsmouth, NH facility begin their use. As Health Canada commits to investing in biomanufacturing and life sciences capacity of CAD 2.2bn across 20 years of announced biomanufacturing projects, under the “Biomanufacturing and Life Sciences Strategy” until 2026, biomanufacturing is emerging as a growing secondary manufacturing sector, with a discrete demand for sterile, single-use processing materials that will fuel greenfield demand in a geography that local supply chains have largely neglected.
Europe represents 23.0% of the global market share and is growing at a 6.8% CAGR, moderated by the maturity of the market, but fueled by a compliance-investment cycle like no other with remarkable regulatory density. Germany also brings in the biggest slice of the region's single national market, where Tetra Pak has its European R&D hub, and it is the biggest single procurement centre for aseptic materials within Central Europe's food and dairy manufacturers. The EU PPWR published in the Official Journal in 2024, sets recyclability and reuse targets to affect globally an estimated 23% of the current aphids packaging formats sold within the bloc. Under the UK's Plastic Packaging Tax, which took effect on 1st April 2022 and was increased to £217 per tonne in 2024 for packaging components made with less than 30% recycled, the financial signal is working to accelerate the process of converting to mono-material (MML) lamination.
Meanwhile, Asia Pacific is also one of the highest-growing markets (8.3% CAGR), and one of the biggest volumes (35.0%) will come from the region over the next five years until 2035. Growth at the national level has been multi-pronged-volume expansion on cost in China, scale-up of manufacturing in India through policy support, and specialization of pharmaceutical materials in Japan and South Korea. Greatview Aseptic Packaging Co. Ltd has six aseptic packaging production lines nationwide; one line was officially put into use in Hohhot, Inner Mongolia in October 2024, which will provide 4 billion packs of annual production capacity; the company now produces 24 billion packs annually for both the domestic and export markets. In addition, the Indian Production Linked Incentive (PLI) scheme for food processors with an outlay of INR 10,900 crore (~USD 1.3 billion) until 2027 is forging on the adoption of aseptic formats among mid-tier food and beverage domestic manufacturers, providing another mid-tier domestic food opportunity for European, APAC and Japanese bolsters, such as Nippon Electric Glass and AGC Inc., who previously operated below the capital intensity threshold required to invest in an aseptic line.
Aseptic Processing & Packaging Materials Market Share
Aseptic Processing & Packaging Materials Market Companies
The major players operating in aseptic processing & packaging materials market include:
Tetra Pak International S.A. is a world leader in aseptic carton packaging materials and filling systems with 58 customer service centers and 12 manufacturing sites for carton packaging materials on four continents. The company aims for scale towards 20% volume sales of bio-based PE barrier carton in Europe, for per-pack carbon intensity below 1.5g CO₂e and for the introduction of a digital quality monitoring system for all filling machine base at the company. The company's R&D spending in 2024 surpassed EUR 300 million with substantial parts invested in fiber-heavy laminate architecture solutions, next generation barrier coating chemistry solutions, and digital printing integration solutions that will help brand owners mitigate the minimum viable order (MVO) volumes inherent in emerging markets.
Philipsen Holding AG, based in Neuhausen am Rheinfall, Switzerland is therefore SIG Combibloc Group AG, Switzerland's second-largest aseptic carton system producer in the world.In Neuhausen am Rheinfall, Switzerland, SIG Combibloc Group AG is Switzerland's second largest aseptic carton system producer worldwide. In 2023 SIG has launched a new carton format, SIG's combiblocXSlim®, for premium dairy and plant-based beverage applications and is now steadily becoming commercial. SIG's drinksPlus® platform, which has been commercially qualified in November 2025 with Oatly AB who have at least 88% paperboard, has SIG firmly established as the top supplier of near-recyclable aseptic carton structures ready for the anticipated PPWR requirements. An Alliance with Smurfit Westrock to support its supply of certified fiber provides an essential upstream input in the areas of paperboard risk of availability.
Amcor plc offers world-class packaging expertise in Aseptic packaging materials - pharmaceutical barrier laminates, retort/food packaging and multi-layer clinical nutrition packaging. The company's extensive manufacturing network across the globe, in 40+ countries and 220+ facilities, provide risk diversification for its pharmaceutical and food customers who may have geographic constraints on their supply chain. The AmLite® recyclable packaging portfolio is moving towards PPWR compliant structures for the aseptic food segment, where APR Critical Guidance has been achieved in 2025.
Elopak AS is an international, narrow-shouldered specialist in aseptic cartoons, who has strong position in the dairy and liquid food markets in Europe and North America. The Pure-Pak® carton family, which has over 700 customers worldwide using it and would have generated more than 14 billion cartons per year by 2024, is one of the three major aseptic carton platforms available. The company's investment of NOK 400 million in its processing plant in Commerce, California, to increase its manufacturing capacity there, is based on a clear decision on market shares in North America where ambient dairy and plant-based beverage demand is growing.
Sartorius AG is the leading provider of traditional single-use bioprocess product components, including the Flexsafe® and Biostat® product families installed at commercial single-use biologics manufacturing facilities around the world on six continents. In 2024, the Bioprocess Solutions division reported EUR 1.85 billion of revenue and single-use materials were reported to represent around 65% of the consumables revenue. High-throughput performance of Sartorius's BioStat STR bioreactor systems (featuring Flexsafe® 3D bioprocess bags) is validated at commercial scale with 2,000-liter working volume, the criterion by which competing single-use bioreactor systems are measured by major biologic drug manufacturers.
Market Share Approximately 18%
Combine Market share is approximately 54%
Aseptic Processing & Packaging Materials Industry News
The aseptic processing & packaging materials market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue (USD Billion) & (Kilo Tons) from 2022 to 2035, for the following segments:
Click here to Buy Section of this Report
Market, By Offering Type
Market, By Material Type
Market, By Application
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →